Tumor histopathology following new sensitizers: Dithiaporphyrin- and sulfoxaporphyrin-mediated photodynamic therapy

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5385-5391

  Symonowicz, K ^a   Ziolkowski P ^a   Chmielewski, P ^b   Latos Grazynski, L ^b   Rabczynski, J ^a   Osiecka, B J ^a   Milach, J ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

BFS1 fibrosarcoma; Dithiaporphyrin; Histopathology; Photodynamic therapy; Sulfoxaporphyrin

Indexed keywords

DITHIAPORPHYRIN; HALOGEN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; SULFOXAPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; FIBROSARCOMA; HISTOPATHOLOGY; IRRADIATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR NECROSIS;

ANIMALS; FIBROSARCOMA; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 0033390073     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Li J-H, Guo Z-H, Jin M-L, Zhao F-Y, Cai W-M, Gao M-L, Shu M-Y, Zou J: "Photodynamic therapy in the treatment of malignant tumours: an analysis of 540 cases". J Photochem Photobiol B: Biol 6: 149-155, 1990.
2. Calzavara F, Tomio L, Corti L, Zorat PL, Barone I, Peracchia A, Norberto L, Flores D, Arcais R, Berti F: "Oesophageal cancer treated by photodynamic therapy alone or followed by radiation therapy". J Photochem Photobiol B: Biol 6: 167-174, 1990.
3. Weinstein GD, MacCullough JL, Nelson JS, Berns MW: "Low dose Photofrin II photodynamic therapy of psoriasis". J Invest Dermatol 96: 573, 1991.
4. Sutedja G, Lam S, LeRiche JC, Postmus PE: "Response and pattern of failure after photodynamic therapy for intraluminal stage I lung cancer". J Bronchol 1, 295-298, 1994.
5. Barr H, Dix T, Roberts D, Shepard N: "Eradication of high grade dysplasia in columnar lined (Barret,s) oesophagus by photodynamic therapy with oral 5-aminolevulinic acid and 630 nm light". Gut 35 (suppl. 5): 7, 1994.
6. Gomer CJ: "Photodynamic therapy in the treatment of malignancies". Sem Hematol 26: 27-34, 1989.
7. Gal D: "Hunt for singlet oxygen under in vivo conditions". Biochem Biophys Res Comm 202: 10-16, 1994.
8. Strizhak P, Kriska T, Gal D: "Mechanism of in vivo photodynamic effects". Proc SPIE 2625: 356-368, 1996.
9. Suwa K, Kimura T, Schaap AP: "Reactivity of singlet molecular oxygen with cholesterol in a phospholipid membrane matrix. A model for oxidative damage of membranes". Biochem Biophys Res Comm 75: 2326-2329, 1977.
10. Egorov SYu, Kamalov VF, Koroteev NI, Krasnovsky Jr AA, Toleutaev BN, Zinukov SV: "Rise and decay kinetics of photosensitized singlet oxygen luminescence in water. Measurements with nanosecond time correlated single photon counting technique". Chem Phys Lett 163: 421-424, 1989.
11. Marcinkowska E, Ziólkowski P, Pacholska E, Latos-Grazynski L, Chmielewski P, Radzikowski Cz: "The new sensitizing agents for photodynamic therapy: 21- selenaporphyrin and 21-thiaporphyrin". Anticancer Res 17: 3313-3320, 1997.
12. Ziólkowski P, Milach J, Symonowicz K, Chmielewski P, Latos-Grazynski L, Marcinkowska E: "5,20-Bis(4-sulphophenyl)-10,15-bis (2-methoxy-4-sulphophenyl)-21-thiaporphyrin as a new potent sensitizer in photodynamic therapy". Tumori 81: 364-369, 1995.
13. Bellnier DA, Ho YK, Pandey RK, Missert JR, Dougherty TJ: "Distribution and elimination of Photofrin II in mice". Photochem Photobiol 50: 221-228, 1989.
14. Kostenich GA, Zhuravkin IN, Furmanchuk AV, Zhavrid EA: "Photodynamic therapy with chlorin e6. A morphologic study of tumor damage efficiency in experiment". J Photochem Photobiol B: Biol 11: 307-318, 1991.
15. Berenbaum MC, Akande SL, Bonnett R, Kaur H, Ioannou S, White RD, Winfield U-J: "Meso-tetra (hydroxyphenyl) porphyrins, a new class of potent tumor photosensitizers with favourable selectivity". Br J Cancer 54: 717-725, 1986.
16. Nelson JS, Roberts WG, Berns MW: "In vivo studies on the utilization of mono-L- aspartyl-chlorin e6 for photodynamic therapy". Cancer Res 47: 4681-4685, 1987.
17. Chaudhuri K, Goldblatt PJ, Kreimer-Birnbaum M, Keck RW, Selman SH. "Histological study of the effect of hematoporphyrin derivative photodynamic therapy on the rat jejunum". Cancer Res 46: 2950-2953, 1986.
18. Latos-Grazynski L, Lisowski J, Szterenberg L, Olmstead MM, Balch AL. "Crystal and molecular structure of 21-thia-5,20-diphenyl-10,15-di-(p-nitrophenyl)porphyrin and 21,23- dithiatetraphenyl porphyrin". J Org Chem 56, 4043-4045, 1991.
19. Pandian RP, Chandrashekar TK. "Water soluble 21-thiaporphyrins and metallo-21- thiaporphyrins; synthesis, characterization, ground-and excited state properties". J Chem Soc Dalton Trans 119-125, 1993.
20. Latos-Grazynski L, Pacholska E, Chmielewski PJ, Olmstead MM, Balch AL: "Alteration of the reactivity of a tellurophene within a core-modified porphyrin environment: synthesis and oxidation of 21-telluraporphyrin". Angew Chem Int Ed Eng 33: 779-781, 1994.
21. Moshfeghi DM, Peyman GA, Moshfeghi AA, Khoobehi B, Primbs GB, Crean DH: "Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies". Ophthalmic Surg Lasers 29: 663-668, 1998.
22. Husain D, Miller JW, Kenney AG, Michaud N, Flotte TJ, Gragoudas ES: "Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative". Ophthalmology 104: 1242-1250, 1997.
23. Ziólkowski P, Symonowicz K, Chmielewski PJ, Latos-Grazynski L, Streckyte G, Rotomskis R, Rabczyώski J: "New sensitizers for photodynamic therapy. The comparison of monothia-, dithia- and sulfoxaporphyrins". J Cancer Res Clin Oncol (in press).
24. Streckyte G, Ziólkowski P, Osiecka B, Symonowicz K, Rotomskis R: "New sensitizer in PDT sulfoxaporphyrin: photophysical properties". Proc IPA, P93 (CD-ROM), 1998.
25. Gomer CJ, Doiron DR, White L, Jester JV, Dunn S, Szirth BC, Razum NJ, Murphree AL: "Hematoporphyrin derivative photoradiation induced damage to normal and tumor tissue of the pigmented rabbit eye". Current Eye Res 3: 229-237, 1984.
26. Rebeiz N, Arkins S, Rebeiz CA, Simon J, Zachary JF, Kelley KW. "Induction of tumor necrosis by delta-aminolevulinic acid and 1, 10 - phenanthroline photodynamic therapy". Cancer Res 56: 339-344, 1996.
27. Fingar VH, Potter WR, Henderson BW: "Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changes". Photochem Photobiol 45: 643-650, 1987.
28. Van Gemert JC, Berenbaum MC, Gijsbers GHM: "Wavelength and light-dose dependence in tumor phototherapy with hematoporphyrin derivative". Br J Cancer 52: 43-49, 1985.
29. Nelson JS, McCullough JL, Berns MW: "Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice". J Natl Cancer Inst 80: 56-60, 1988.
30. Benson Jr. RC, Kinsey JH, Cortese DA, Farrow GM, Utz DC: "Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy". J Urology 130: 1090-1095, 1983.